The global home infusion therapy market exhibited moderate growth during 2015-2020.
Looking forward, the analyst expects the market to grow at a CAGR of around 7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.
Home infusion therapy is a medical procedure used for the (IV) or subcutaneous administration of drugs or biologics to a patient at home. It involves the infusion of medications, such as antivirals or immune globin, through various equipment, including pumps, catheters and vials. The therapy is effective in chemotherapy and hydration, enteral, inotropic, anti-infective, nutritional and pain management therapies for the treatment of diabetes and various gastrointestinal and oncological disorders. It facilitates self-administration of drugs in medical conditions where oral medications are not effective.
Home Infusion Therapy Market Trends: The increasing prevalence of chronic medical ailments, such as cancer, osteoarthritis and diabetes, and the shifting preference for at-home treatments among the masses, is one of the key factors driving the growth of the market. The rising incidence of hospital-acquired infections (HAIs) due to exposure to contaminated equipment, bed linens and air droplets across facilities is also providing a thrust to the market growth. Moreover, as the coronavirus disease (COVID-19) continues to spread across the globe, there has been a significant increase in the demand for home infusion therapies to minimize the risks of contracting the infection and ensuring optimal treatment. Additionally, the development of cost-effective and user-friendly home infusion kits is acting as another growth-inducing factor. These novel variants are lightweight, portable and easy to use for the patients and caregivers and are also equipped with advanced drip systems for precise and real-time monitoring of IV treatments. Other factors, including the rising geriatric population, which is more susceptible to medical ailments, along with significant improvements in the healthcare infrastructure, are anticipated to drive the market toward growth.
Key Market Segmentation: the analyst provides an analysis of the key trends in each sub-segment of the global home infusion therapy market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product and application.
Breakup by Product: Infusion Pumps Elastomeric Electromechanical Gravity Others Intravenous Sets IV Cannulas Needleless Connectors
Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa
Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Eli Lilly and Company, Fresenius SE & Co. KGaA, ICU Medical Inc., JMS Co. Ltd., Nipro Corporation, Option Care Health Inc. (Walgreen Co.), Smiths Group plc and Terumo Corporation. Key Questions Answered in This Report: How has the global home infusion therapy market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global home infusion therapy market? What are the key regional markets? What is the breakup of the market based on the product? What is the breakup of the market based on the application? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global home infusion therapy market and who are the key players? What is the degree of competition in the industry?
Our reports have been used by over 10K customers, including:
The global intravenous solutions market reached a value of US$ 13.2 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 18.6 Billion by 2027, exhibiting a CAGR of 5.96% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence...
The global alopecia treatment market reached a value of US$ 3 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 3.9 Billion by 2027, exhibiting a CAGR of 4.7% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as...
The frozen tissues samples market is projected to reach US$ 105,045.91 Thousand by 2028 from US$ 44,399.07 Thousand in 2021; it is estimated to grow at a CAGR of 13.1% during 2021-2028. The report highlights trends prevailing in the market and the factors driving it.The growth of the frozen tissues samples market is attributed to the...
200 pages •
By The Business Research Company
• May 2022
Major players in the anatomical pathology equipment and consumables market are Epridea, F. Hoffmann-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific, Sakura Finetek, Agilent Technologies, Danaher Corporation, Bio SB, BioGenex Laboratories, and Quest Diagnostics Incorporated. The global anatomic pathology equipment and consumables...
175 pages •
By The Business Research Company
• May 2022
Major players in the critical illness market are China Life Insurance, Allianz, Ping An Insurance, Aviva, Legal & General, China Pacific Insurance, Prudential plc, New China Life Insurance, Aegon, and AXA. The global critical illness insurance market is expected to grow from $185.53 billion in 2021 to $215.49 billion in 2022 at a compound...
Deep brain stimulation (DBS) therapies target a growing number of existing indications, including movement disorders and neuropsychiatric conditions, and newer areas such as lifestyle disorders, including diabetes and obesity.This will allow more patients to benefit from the therapy. According to the WHO, neurological diseases currently...
The global surrogacy market reached a value of US$ 161.83 Million in 2021. Looking forward, the analyst expects the market to reach a value of US$ 240.56 Million by 2027, exhibiting a CAGR of 6.62% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect...
Non Alcoholic Fatty Liver Disease (NAFLD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Non Alcoholic Fatty Liver Disease (NAFLD) - Drugs in Development by Stages, Target, MoA,...
Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 126.96.36.199) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 188.8.131.52) - Janus kinase 2 is a non-receptor tyrosine...
250 pages •
By The Business Research Company
• Mar 2022
Major players in the ultra-low temperature freezers market are Arctiko, Eppendorf, Esco Micro Pte Ltd, Haier, Helmer Scientific, Bionics Scientific Technologies (P). Ltd, PHC Holdings Corporation, Labcold Ltd, Remi Group, and Stirling Ultracold. The global ultra-low temperature freezers market is expected to grow from $805.47 million...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.